References
Lee WM: Drug-induced hepatotoxicity. N Engl J Med 349:474-485, 2003
Breuer HW, Bossek W, Haferland C, et al.: Amiodarone-induced severe hepatitis mediated by immunological mechanisms. Int J Clin Pharmacol Ther 36:350-352, 1998
Lewis JH, Ranard RC, Caruso A, et al.: Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients. Hepatology 9:679-685, 1989
Kanji Z, Sunderji R, Gin K: Amiodarone-induced pulmonary toxicity. Pharmacotherapy 19:1463-1466, 1999
Singhal A, Ghosh P, Khan SA: Low dose amiodarone causing pseudo-alcoholic cirrhosis. Age Ageing 32:224-225, 2003
Modolell I, Guarner L, Malagelada JR: Vagaries of clinical presentation of pancreatic and biliary tract cancer. Ann Oncol 10 (Suppl) 4:82-84, 1999
Chang CC, Petrelli M, Tomashefski JF Jr, et al.: Severe intrahepatic cholestasis caused by amiodarone toxicity after withdrawal of the drug: a case report and review of the literature. Arch Pathol Lab Med 123:251-256, 1999
Assy N, Jacob G, Spira G, et al.: Diagnostic approach to patients with cholestatic Jaundice. W J Gastroenterol 15:252-262, 1999
Stieger B, Fattinger K, Madon J, et al.: Drug-and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology 118:422-430, 2000
Spaniol M, Bracher R, Ha HR, Follath F, Krähenbühl S: Toxicity of amiodarone and amiodarone analogues on isolated rat liver Mitochondria. J Hepatol 35:628-636, 2001
Simon JB, Manley PN, Brien JF, et al.: Amiodarone hepatotoxicity simulating alcoholic liver disease. N Engl J Med 311:167-172, 1984
Adams PC, Bennett MK, Holt DW: Hepatic effects of amiodarone. Br J Clin Pract Suppl 44:81-95, 1986
Burger A, Dinichert D, Nicod P, et al.: Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones. J Clin Invest 58:255-259, 1976
Guigui B, Perrot S, Berry JP, et al.: Amiodarone-induced hepatic phospholipidosis: a morphological alteration independent of pseudoalcoholic liver disease. Hepatology 8:1063-1068, 1988
Sarma JS, Pei H, Venkataraman K: Role of oxidative stress in amiodarone-induced toxicity. J Cardiovasc Pharmacol Ther 2:53-60, 1997
Vereckei A, Blazovics A, Gyorgy I, et al.: The role of free radicals in the pathogenesis of amiodarone toxicity. J Cardiovasc Electrophysiol 4:161-177, 1993
Ruch RJ, Bandyopadhyay S, Somani P, et al.: Evaluation of amiodarone free radical toxicity in rat hepatocytes. Toxicol Lett 56:117-126, 1991
Trujillo TC, Nolan PE: Antiarrhythmic agents: drug interactions of clinical significance. Drug Saf 23:509-532, 2000
Handler JA, Brian WR: Effect of aging on mixed-function oxidation and conjugation by isolated perfused rat livers. Biochem Pharmacol 54:159-164, 1997
Schmucker DL: Aging and the liver: an update. J Gerontol A Biol Sci Med Sci 3:B315-B320, 1998
Ehrenpreis ED, Ehrenpreis S: Cytochrome P450; Role in drug-induced hepatotoxicity. Clin Liver Dis 2:457-468, 1998
Reshef R, Cohen I, Shiller M, et al.: Does ursodeoxycholic acid have a place in the treatment of amiodarone-induced cholestasis? J Clin Gastroenterol 18:177-178, 1994
Leeder RG, Brien JF, Massey TE: Investigation of the role of oxidative stress in amiodarone-induced pulmonary toxicity in the hamster. Can J Physiol Pharmacol 72:613-621, 1994
Card JW, Leeder RG, Racz WJ, et al.: Effects of dietary vitamin E supplementation on pulmonary morphology and collagen deposition in amiodarone-and vehicle-treated hamsters. Toxicology 133:75-84, 1999
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Assy, N., Khair, G., Schlesinger, S. et al. CASE REPORT: Severe Cholestatic Jaundice in the Elderly Induced by Low-Dose Amiodarone. Dig Dis Sci 49, 450–452 (2004). https://doi.org/10.1023/B:DDAS.0000020501.09248.1f
Issue Date:
DOI: https://doi.org/10.1023/B:DDAS.0000020501.09248.1f